NRIX
Nurix Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.32 / 10
Outperform
Analyst sentiment is overwhelmingly positive: 4 Strong Buy and 3 Buy recommendations, weighted rating 7.02. Fund‑flow patterns show overall inflow (0.48) with small, medium and large investors net buying, though block and extra‑large flows are negative.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
57%
Buy
43%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-29
InstitutionRBC Capital
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for NRIX?
- NRIX holds a Bullish analyst rating, with 57% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.32/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
